Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects

Metabolism: Clinical and Experimental

Volumn 45, Issue 12, 1996, Pages 1514-1520

  Schuster, Dara P ^a   Osei, Kwame ^a   Zipf, William B ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRADER WILLI SYNDROME; PRIORITY JOURNAL;

EID: 0030447214     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90181-X     Document Type: Article

References (37)

1. Rizza R, Mandarino L, Gerich J: Mechanisms of insulin resistance in man. Assessment using the insulin dose-response curve in conjunction with insulin-receptor binding. Am J Med 70:169-175, 1981
2. Doeden B, Rizza R: Use of a variable insulin infusion to assess insulin action in obesity: Defects in both the kinetics and amplitude of response. J Clin Endocrinol Metab 64:902-908, 1987
3. Reaven G, Brand R, Chen Y, et al: Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 42:1324-1332, 1993
4. Beard J, Ward W, Halter J, et al: Relationship of islet function to insulin action in human obesity. J Clin Endocrinol Metab 65:59-64, 1987
5. Atrenisio A, Ragonese F, Forte F, et al: Insulin and C-peptide in obesity: Relationship with insulin receptors and insulin sensitivity, in Recent Advances in Obesity and Diabetes Research. 1984, pp 35-48
6. Lillioja S, Nyomba B, Saad M, et al: Exaggerated early insulin release and insulin resistance in a diabetes-prone population: A metabolic comparison of Pima Indians and caucasians. J Clin Endocrinol Metab 73:866-876, 1991
7. Martin B, Warram J, Krolewshi A, et al: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study. Lancet 340:925-929, 1992
8. Donaldson MDC, Chu CE, Cooke A, et al: The Prader-Willi syndrome. 70:58-63, 1994 (review)
9. Cassidy S: Prader-Willi syndrome. Curr Probl Pediatr 14:5-55, 1984
10. Nozaki Y, Katoh K: Endocrinological abnormalities in Prader-Willi syndrome. Acta Paediatr Jpn 23:301-306, 1981
11. Parra A, Cervantes C, Schultz R: Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndrome. J Pediatr 83:587-593, 1973
12. Bier DM, Kaplan SL, Havel RJ: The Prader-Willi syndrome: Regulation of fat transport. Diabetes 26:874-881, 1977
13. Hall B, Smith D: Prader-Willi syndrome. J Pediatr 81:286-293, 1972
14. Zipf WB, Odorisio TM, Cataland S, et al: Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome. J Clin Endocrinol Metab 57:1074-1080, 1983
15. Tomita T, Greeley G, Watt L, et al: Protein meal-stimulated pancreatic polypeptide secretion in Prader-Willi syndrome of adults. Pancreas 4:395-400, 1989
16. Shapiro ET, Tillil H, Miller MA, et al: Insulin secretion and clearance: Comparison after oral and intravenous glucose. Diabetes 36:1365-1371, 1987
17. Shuster LT, Go VLW, Rizza RA, et al: Incretin effect is due to increased secretion and decreased clearance of insulin in normal humans. 37:200-203, 1988
18. Nauck MA, Hornberger E, Siegel EG, et al: Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492-498, 1986
19. Katz AL, Rubenstein AH: Metabolism of proinsulin, insulin and C-peptide in rats. J Clin Invest 52:1133-1118, 1983
20. Polonsky KS, Rubenstein AH: C-peptide as a measure, of the secretion and hepatic extraction of insulin. Diabetes 33:486-494, 1984
21. National Diabetes Criteria Data Groups: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1-57, 1979
22. Holm VA, Cassidy SB, Butler MG, et al: Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 91:398-402, 1993
23. Segal KR, Loan MC, Fitzgerald PL, et al: Lean body mass estimation by bioelectrical impedance analysis: A four-site cross-validation study. Am J Clin Nutr 47:4-17, 1988
24. Ader M, Pacini G, Yang YJ, et al: Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements. Diabetes 34:1092-1103, 1985
25. Kuzuya H, Blix PM, Horwitz DL, et al: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:2229, 1977
26. Osei K, Cottrell DA, Orabella MM: Insulin sensitivity, glucose effectiveness and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care 14:890-896, 1991
27. Radziuk J, Morishima T: Assessment of insulin kinetics in vivo, in Lanner J, Pohl SL (eds): Methods in Diabetes Research. New York, NY, Wiley, 1986, pp 91-106
28. Fukushima M, Tokunaga K, Lupien J, et al: Dynamic and static phases of obesity following lesions of PVN and VMH. II. Am J Physiol 253:523-529, 1987
29. Bruce DG, Chisholm DJ, Storlien LH, et al: Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes 37:736-744, 1988
30. Colwell JA, Lein A: Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes 16:560-565, 1967
31. Luzi L, DeFronzo RA: Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol 257:E241-E246, 1989
32. Berthoud H-R, Powley TL: Morphology and distribution of efferent vagal innervation of rat pancreas as revealed with anterograde transport of Dil. Brain Res 553:336-341, 1991
33. Schwartz TW: Pancreatic polypeptides: A hormone under vagal control. Gastroenterology 85:1411-1419, 1983
34. Polonsky KS, Given BD, Hirsch L, et al: Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81:435-441, 1988
35. Osei K, Holland GC: Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients. Metabolism 36:122-127, 1987
36. Cozzolino D, Sessa G, Salvatore T, et al: Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: The role played by abnormal clearance of insulin. Metabolism 44:1278-1282, 1995
37. Freedman DS, Srinivasan SR, Burke GL, et al: Relation of body fat distribution to hyperinsulinemia in children and adolescents: The Bogalusa Heart Study. J Clin Nutr 46:403-410, 1987